Literature DB >> 25608699

Vascular chronic Q fever: quality of life.

J C J P Hagenaars1, P C Wever2, S O A Shamelian3, A S Van Petersen4, M Hilbink5, N H M Renders2, G L De Jager-Leclercq6, F L Moll7, O H J Koning1.   

Abstract

The aim of this study was to evaluate the quality of life in patients with vascular chronic Q fever at time of diagnosis and during follow-up. Based upon the SF-36 questionnaire, the mean physical and mental health of each patient were assessed at 3-month intervals for up to 18 months. A total of 26 patients were included in the study. At time of diagnosis, the mean physical health and mental health score was 50·6 [95% confidence interval (CI) 46·7-54·4] and 44·6 (95% CI 41·6-47·5), respectively. During treatment, the mean physical health score declined significantly by 1·7 points each 3 months (P < 0·001) to 40·8 (95% CI 34·4-45·1). The mean mental health score significantly and steadily increased towards 51·2 (95% CI 46·9-54·3) during follow-up (P = 0·026). A total of 23% of patients were cured after 18 months of follow-up. In conclusion, quality of life at time of diagnosis for patients with vascular chronic Q fever is lower compared to a similar group of patients, matched for age and gender, with an aortic abdominal aneurysmal disease, and physical health decreases further after starting treatment. Considering the low percentage of cure, the current treatment of vascular chronic Q fever patients may require a separate strategy from that of endocarditis in order to increase survival.

Entities:  

Keywords:  Health statistics; Q fever; infectious disease; zoonoses

Mesh:

Year:  2015        PMID: 25608699      PMCID: PMC9151017          DOI: 10.1017/S0950268814003951

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  20 in total

1.  Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study.

Authors:  G J M Limonard; J B Peters; M H Nabuurs-Franssen; G Weers-Pothoff; R Besselink; C A R Groot; P N R Dekhuijzen; J H Vercoulen
Journal:  QJM       Date:  2010-08-27

2.  Saphenous vein spiral graft: successful emergency repair of a mycotic aneurysm with aortoduodenal fistula.

Authors:  J T Heikens; H M E Coveliers; D H C Burger; D P van Berge Henegouwen; P W Vriens
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-06-16       Impact factor: 7.069

Review 3.  Vascular complications of Q-fever infections.

Authors:  M C A Wegdam-Blans; T Vainas; M R van Sambeek; P W Cuypers; H T J Tjhie; A H M van Straten; J A Teijink
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-05-31       Impact factor: 7.069

4.  Targeted screening as a tool for the early detection of chronic Q fever patients after a large outbreak.

Authors:  M C A Wegdam-Blans; R A Stokmans; J H T Tjhie; J M Korbeeck; M P Koopmans; S M A A Evers; P H van der Voort; J A W Teijink
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-26       Impact factor: 3.267

5.  Long-term outcome of Q fever endocarditis: a 26-year personal survey.

Authors:  Matthieu Million; Franck Thuny; Hervé Richet; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2010-07-14       Impact factor: 25.071

6.  Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort.

Authors:  M J Wildman; E G Smith; J Groves; J M Beattie; E O Caul; J G Ayres
Journal:  QJM       Date:  2002-08

7.  The effect of C. burnetii infection on the quality of life of patients following an outbreak of Q fever.

Authors:  T F Hatchette; M Hayes; H Merry; W F Schlech; T J Marrie
Journal:  Epidemiol Infect       Date:  2003-06       Impact factor: 2.451

8.  Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome.

Authors:  E Botelho-Nevers; P-E Fournier; H Richet; F Fenollar; H Lepidi; C Foucault; A Branchereau; P Piquet; M Maurin; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

9.  Estimated prevalence of chronic Q fever among Coxiella burnetii seropositive patients with an abdominal aortic/iliac aneurysm or aorto-iliac reconstruction after a large Dutch Q fever outbreak.

Authors:  Julia C J P Hagenaars; Peter C Wever; André S van Petersen; Peter J Lestrade; Monique G L de Jager-Leclercq; Mirjam H A Hermans; Frans L Moll; Olivier H J Koning; Nicole H M Renders
Journal:  J Infect       Date:  2014-03-16       Impact factor: 6.072

10.  Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date.

Authors:  Joris Af van Loenhout; W John Paget; Jan H Vercoulen; Clementine J Wijkmans; Jeannine L A Hautvast; Koos van der Velden
Journal:  BMC Infect Dis       Date:  2012-10-30       Impact factor: 3.090

View more
  3 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Treatment and Prophylactic Strategy for Coxiella burnetii Infection of Aneurysms and Vascular Grafts: A Retrospective Cohort Study.

Authors:  Carole Eldin; Morgane Mailhe; Caroline Lions; Patrizia Carrieri; Hazem Safi; Philippe Brouqui; Didier Raoult
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

3.  Impact of Q-fever on physical and psychosocial functioning until 8 years after Coxiella burnetii infection: An integrative data analysis.

Authors:  Daphne F M Reukers; Cornelia H M van Jaarsveld; Reinier P Akkermans; Stephan P Keijmel; Gabriella Morroy; Adriana S G van Dam; Peter C Wever; Cornelia C H Wielders; Koos van der Velden; Joris A F van Loenhout; Jeannine L A Hautvast
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.